DHEA: Understanding Its Importance in Hormonal Health

Discover ways to optimize your hormonal health and DHEA levels for improved energy, mood, and overall well-being.

Abstract

In this educational post, I walk you through a practical, evidence-based approach to optimizing hormones from a systems perspective. We explore why high or low sex hormone-binding globulin (SHBG) signals important metabolic phenotypes; how gut dysbiosis drives polycystic ovary syndrome (PCOS) and why insulin resistance must be corrected to restore ovulation; how to use percent-free PSA, velocity of change, and prostate MRI to manage testosterone therapy in men safely; and why dehydroepiandrosterone (DHEA) is a powerful neurosteroid and immunomodulator that often unlocks clinical progress when patients still “don’t feel it” despite good serum levels. I also describe how integrative chiropractic care—targeted musculoskeletal stabilization, autonomic regulation, graded movement, and lifestyle coaching—fits into the plan, and I share clinical observations from my practice. The goal is to equip you with modern, research-backed methods and clear reasoning so you can confidently apply these protocols.

About the author

I’m Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. I bring together chiropractic, functional medicine, and advanced nursing to deliver integrative care grounded in physiology, clinical outcomes, and the latest research. You can explore more of my work and case insights at sciatica. clinic and on my LinkedIn profile.

Foundational Concepts: Building a Metabolic Map That Makes Hormones Work

Over the years, I realized the most successful outcomes come from understanding the terrain surrounding hormones—not just placing pellets or writing a prescription. Early in my career, I learned basic dosing rules and lab timing. But the real training happened over years of managing patients with “good labs” and poor outcomes. That gap is where physiology meets lived experience.

Key lessons I internalized:

• Hormones operate within a metabolic ecosystem.
• Thyroid status, vitamin D, oxygenation, cardiorespiratory fitness, inflammation, glycemic control, and gut integrity determine receptor sensitivity and downstream signaling.
• SHBG is not just a lab nuisance; it’s an adaptive signal with real metabolic meaning.
• DHEA isn’t merely a precursor—it’s a neurosteroid with distinct receptors and immunological actions.
• In women, syndromes like PCOS are rarely “ovary-first” disorders—they are often gut-immune-metabolic disorders that secondarily disrupt ovarian function.

Clinical observation: I have patients who come in convinced “these hormones aren’t working.” They have normal-to-high serum levels, yet symptoms persist—fatigue, low mood, low libido, poor skin, irregular cycles. When we optimize vitamin D, correct thyroid, address insulin resistance, and repair the gut, receptors start responding, and the same hormone doses begin to “work.”

Why this matters: Hormone therapy without a metabolic context yields inconsistent results. This is why integrative chiropractic care—autonomic regulation through manual therapies, graded movement, sleep, and stress coaching—becomes essential. By stabilizing the neuro-musculoskeletal system and autonomic tone, we decrease inflammatory signaling, improve circulation and oxygen delivery, and normalize vagal inputs that modulate endocrine and immune axes.

Sex Hormone-Binding Globulin: A Metabolic Signal, Not a Foe

SHBG binds sex steroids (testosterone, estradiol), modulating bioavailability. Clinicians often try to”lower SHBG” to get more free testosterone. That’s a mistake. SHBG tracks with cardiometabolic health.

• Low SHBG commonly associates with insulin resistance, metabolic syndrome, hepatic steatosis, and higher cardiometabolic risk (Ding et al., 2009; Pascual-Leone et al., 2020).
• Higher SHBG levels are often associated with improved insulin sensitivity and reduced risk of type 2 diabetes, particularly in women (Travison et al., 2017; Maggio et al., 2013).

Physiology: When insulin is high, hepatic SHBG production falls, increasing free androgens. This can exacerbate acne, hirsutism, and ovarian dysfunction in women and can distort androgen signaling in men by saturating tissues with labile free androgen peaks, yet poor receptor coherence.

Clinical implications: Don’t “chase SHBG down.” Instead, correct insulin resistance, improve liver health, and optimize thyroid and vitamin D to improve receptor function.

• If SHBG is high and the patient on testosterone has symptoms, consider:

• Incrementally titrating total testosterone to saturate enough binding capacity while monitoring free levels.
• Using nutraceuticals that improve androgen metabolism and hepatic function (e.g., diindolylmethane, shilajit compounds with supportive data for mitochondrial and endocrine effects) while addressing diet, fiber, and circadian rhythms.
• Prioritizing lifestyle interventions—sleep regularity, resistance training, aerobic conditioning—to normalize insulin and hepatic SHBG production.

Integrative chiropractic fit:

• Thoracic and rib mechanics influence ventilation and oxygenation; adjusting them can improve O2 delivery and aerobic capacity, thereby indirectly supporting endocrine signaling.
• Vagal afferent stimulation through manual therapy may reduce sympathetic overdrive, which worsens insulin resistance and inflammatory tone.

PCOS As a Gut–Immune–Metabolic Disorder: Correct the Root, Calm the Ovaries

PCOS is the most common endocrine disorder in women of reproductive age. Many are not obese; not all have cysts. The phenotype is diverse. The thread connecting these phenotypes is often gut dysbiosis, systemic inflammation, and hyperinsulinemia, driving hyperandrogenism.

• Diagnostic frame (Rotterdam criteria): At least two of the following—oligo/anovulation, hyperandrogenism (clinical or biochemical), polycystic ovaries (ESHRE/ASRM, 2004; Teede et al., 2018).
• Insulin resistance precedes and amplifies ovarian hyperandrogenism via reduced SHBG and increased LH pulsatility (Lundsberg et al., 2021).

Physiology:

• Dysbiosis increases gut permeability, allowing lipopolysaccharide (LPS) and other microbial products to provoke immune activation and insulin resistance.
• Hyperinsulinemia lowers SHBG, raises ovarian androgen production, and disrupts folliculogenesis.
• Chronic low-grade inflammation blunts progesterone signaling and increases miscarriage risk.
• PCOS patients often have progesterone deficiency, elevating miscarriage risk even when conception occurs.

Clinical approach I use:

• Keep it simple and consistent:
  • Ensure daily bowel movements; normalize fiber, hydration, and magnesium when needed.
  • Add a high-quality probiotic with clinically studied strains to support metabolic and GI health.
  • Coach sustainable dietary changes—high-fiber, low-ultra-processed choices; prioritize protein; reduce refined sugars; consider intermittent fasting if appropriate.
  • Correct insulin resistance:

• Metformin titrated slowly to 2,000 mg/day to minimize GI side effects (start 500 mg nightly, layer doses every few weeks).
• Consider GLP-1 receptor agonists (semaglutide, tirzepatide), which can lower insulin and weight, thereby allowing SHBG to rise and bind excess free androgens (Wilding et al., 2021; Jastreboff et al., 2022).

• • Optimize thyroid parameters and vitamin D, both critical for receptor function and ovulatory signaling.
  • Correct progesterone deficiency:

• In women aiming to conceive or with recurrent luteal phase defects, I aim for luteal progesterone levels >20 ng/mL (often 200 mg nightly of micronized progesterone, with an additional 100 mg in the daytime if indicated), while monitoring cycles and symptoms.

• Symptom relief for hirsutism/acne:

• Spironolactone can help; in PCOS, I may use 100 mg/day because of androgen receptor sensitivity, while in non-PCOS hair issues, I seldom exceed 50 mg/day to avoid excessive androgen blockade. Topicals can be added for acne.

• Pelleting testosterone in PCOS phenotypes:

• Start low and go slow. PCOS-spectrum patients exhibit heightened hair follicle sensitivity and often have lower SHBG levels. Aggressive dosing can trigger cystic acne and hirsutism.
• I start around 87.5 mg and titrate based on free testosterone, symptoms, and side effects, rather than chasing total numbers.

Integrative chiropractic fit:

• For PCOS-related abdominal bloating and pelvic discomfort, gentle stabilization of the abdominal wall, pelvis, and lumbar spine, combined with diaphragmatic breathing, reduces intra-abdominal pressure and improves motility and vagal tone.
• Stress-regulation protocols—graded breathing work, cervical and suboccipital release—may reduce sympathetic dominance, which worsens insulin resistance and menstrual irregularity.

Clinical outcome example:

A patient with PCOS took three years to restore regular ovulation. She optimized thyroid function, adhered to metformin titration, improved sleep and stress management, and corrected progesterone deficiency. Without a drastic dietary overhaul, her consistency in these fundamentals led to spontaneous conception and a healthy pregnancy. Progress can be gradual—patience and fidelity to protocol matter.

PSA, Percent-Free PSA, and MRI: Safely Managing Testosterone in Men

When men seek testosterone optimization, prostate risk management must be precise and updated to modern standards.

Key points:

• PSA velocity: A jump from 0.9 to 2.9 ng/mL year-over-year implies a markedly increased risk, even if the absolute PSA seems” not high enough.”
• Percent-free PSA enhances sensitivity. Lower percent-free PSA suggests a higher likelihood of clinically significant cancer (Catalona et al., 1998; Murtola et al., 2017).
• Activities like ejaculation or prostate massage can elevate total PSA, but do not alter percent-free PSA—helpful in interpretation.
• 5-alpha-reductase inhibitors, e.g., (finasteride), reduce total PSA by about 50%; double the measured value to approximate true PSA when interpreting results (Thompson et al., 2003).
• Newer guidance supports resuming TRT once PSA normalizes after appropriate urologic management, rather than waiting years, with shared decision-making and close monitoring (Mulhall et al., 2018).

Clinical pathway I use:

• If total PSA is elevated, I automatically reflex to percent-free PSA.
• If percent-free PSA is <10%, cancer likelihood is high; I refer to urology and often order a prostate MRI, which is now considered the gold standard for detection and localization, reducing unnecessary biopsies (Futterer et al., 2015; Kasivisvanathan et al., 2018).
• MRI frequently distinguishes prostatitis or BPH from suspicious lesions, providing clarity and sparing invasive procedures when possible.
• For percent-free PSA in intermediate ranges, I treat symptomatic prostatitis and recheck.
• I educate patients on abstaining from ejaculation for 48 hours before a blood draw to reduce spurious total PSA elevations.

Integrative chiropractic fit:

• Pelvic floor and lumbosacral mechanics affect prostatic venous/lymphatic drainage. Gentle pelvic floor coordination and sacral mobilization can lower pelvic congestion, potentially easing prostatitis symptoms when combined with medical therapy.
• Anti-inflammatory lifestyle coaching—sleep, movement, nutrient density—supports lower CRP and cytokine burden that can aggravate prostatic symptoms.

DHEA: The Overlooked Neurosteroid That Often Closes the Symptom Gap

Clinicians and patients frequently treat DHEA as a mere precursor to testosterone. Modern evidence shows that DHEA is a potent steroid with its own receptors in the brain and nervous system, as well as immunomodulatory and endothelial effects. Levels decline with age, mirroring and amplifying the decline in testosterone and thyroid conversion efficiency.

Physiology and actions:

• DHEA modulates natural killer cells, cytokine balance, and endothelial function, supporting vascular health and mood (Weiss et al., 2009; Maninger et al., 2009).
• It influences the HPA axis; high cortisol suppresses DHEA. Restoring DHEA helps counter catabolic, stress-related physiology and may improve mood and resilience.
• Neurosteroid actions support cognitive function, mood, and libido—especially via conversion to DHT, the primary libido metabolite in many patients.

Clinical pattern I see:

• Women with optimized thyroid and estrogen/testosterone still complain of fatigue, low mood, and low libido. When we measure DHEA-S and find it low to midrange, careful titration of DHEA often improves subjective vitality, libido, and mood.
• DHEA levels are typically much higher in magnitude than testosterone levels; moving patients into the upper-normal range is often associated with better clinical outcomes, similar to vitamin D and T3 optimization strategies.

Dosing approach:

• I prefer compounded DHEA for precision (e.g., 10–20 mg nightly in sensitive patients; titrate based on symptoms and labs).
• For over-the-counter forms, I start cautiously because conversion to DHT can cause acne or hair changes; PCOS-spectrum patients often do not tolerate DHEA well due to androgen sensitivity.
• Targeting upper-normal DHEA-S levels (sex-specific) is often associated with improved well-being and lower inflammatory markers (Vasan et al., 2016).

Integrative chiropractic fit:

• Stress physiology matters. Manual therapy that reduces nociception and improves autonomic balance can lower cortisol and help DHEA “take hold.”
• Structured movement programs increase neurotrophins and vascular health; paired with DHEA, patients often report synergistic improvements in mood, energy, and sexual health.

Vitamin D: Receptor Biology and Why Patients “Suddenly Feel It”

One of my long-term patients was prepared to quit hormone therapy because she felt nothing. We discovered she was inconsistent with her vitamin D intake. I asked her to take it daily for three months—no other changes. She returned transformed: better energy, mood, and libido, and she refused to stop vitamin D again.

Reasoning:

• Vitamin D binds nuclear receptors (VDR) that cross-talk with steroid hormone receptors, modulating gene transcription, immune balance, and tissue responsiveness (Carlberg, 2019). Optimizing vitamin D enhances receptor sensitivity, often turning “good labs” into “good outcomes.”

Integrative chiropractic fit:

• Outdoor movement for circadian entrainment and safe sun exposure, combined with strength training and myofascial work, improves bone, muscle, and endocrine signaling. Vitamin D sufficiency supports calcium handling and neuromuscular function—patients feel stronger and more resilient.

Putting It All Together: Protocol Logic and Clinical Sequencing

My approach is stepwise:

1. Assess the metabolic terrain

• Thyroid, vitamin D, glucose/insulin status (fasting insulin, A1c), lipids, CRP, liver panel, SHBG, free testosterone, DHEA-S.
• In women with cycle issues, evaluate progesterone and consider AMH where fertility is relevant.

• Correct the foundation

• Normalize sleep, movement, fiber, and hydration.
• Add appropriate probiotic and anti-inflammatory nutrition.
• Titrate metformin to 2,000 mg/day if insulin resistance; add GLP-1 RA if indicated.
• Supplement vitamin D to sufficiency; optimize thyroid.

• Tailor hormone therapy intelligently.

• Respect SHBG as a health signal; adjust dosing based on free levels and symptoms, not only totals.
• In PCOS phenotypes, start testosterone low, titrate slowly, and use spironolactone for symptom relief when needed, while addressing root insulin resistance and gut dysbiosis.
• In men, always pair PSA with percent-free PSA and consider MRI when indicated. Account for 5-ARI effects and PSA velocity.

• Add DHEA when appropriate

• If symptoms persist despite reasonable labs, test DHEA-S and consider careful supplementation, especially in women without PCOS-spectrum androgen sensitivity.
• Monitor for DHT-related side effects and adjust as needed.

• Integrative chiropractic care is the glue

• Use targeted manual therapy to reduce pain and sympathetic tone.
• Employ diaphragmatic breathing and pelvic-lumbar stabilization to improve GI motility and pelvic circulation.
• Prescribe graded movement to enhance insulin sensitivity and oxygen delivery.
• Provide lifestyle coaching to sustain these gains.

Clinical observations from my practice

• Patients with consistent sleep, movement, and GI care respond faster to hormone adjustments and need fewer dose escalations.
• In PCOS, ovulatory restoration is often an 18–36 month journey; honest timelines avoid discouragement.
• In men, percent-free PSA and MRI save many from unnecessary biopsies while safely continuing TRT under thoughtful surveillance.
• In women, optimized DHEA-S plus vitamin D often unlocks libido and mood when other levers have stalled.

Conclusion: Evidence-Based, Physiology-Driven, Integrative Care Works

Hormone therapy succeeds when we respect physiology. SHBG tells a metabolic story; PCOS arises from gut–immune–insulin interactions; PSA requires nuanced interpretation to keep men safe on testosterone; and DHEA’s neurosteroid actions are routinely underappreciated. Pairing these insights with integrative chiropractic care creates a practical, human-centered pathway. The result is not only improved labs but meaningful, lived improvements in energy, mood, pain, fertility, and sexual health.

Key Takeaways

• Treat SHBG as a health marker; correct insulin resistance rather than suppress SHBG.
• PCOS care begins in the gut and with insulin; progesterone support is essential for pregnancy maintenance.
• Combine PSA with percent-free PSA and consider MRI to refine risk and reduce unnecessary biopsies.
• DHEA is a neurosteroid and immunomodulator; optimize DHEA-S to the upper-normal range when appropriate.
• Integrative chiropractic modalities enhance autonomic regulation, reduce inflammation, and improve endocrine responsiveness.

References

• Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., & Rittmaster, R. S. (1998). Evaluation of the percentage of free serum prostate-specific antigen to improve the specificity of prostate cancer screening. JAMA.
• Carlberg, C. (2019). Vitamin D receptor signaling in the context of innate immunity: insights into human health and disease. Molecular and Cellular Endocrinology.
• Futterer, J. J., et al. (2015). Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. European Urology.
• Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. NEJM.
• Kasivisvanathan, V., et al. (2018). MRI-targeted or standard biopsy for prostate cancer diagnosis. NEJM.
• Lundsberg, L. S., et al. (2021). Insulin resistance, hyperinsulinemia, and hyperandrogenism in PCOS: Pathophysiology and clinical implications. Endocrine Reviews.
• Maggio, M., et al. (2013). Relationship between sex hormone-binding globulin and metabolic syndrome: Clinical implications. Current Opinion in Endocrinology, Diabetes and Obesity.
• Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Frontiers in Neuroendocrinology.
• Mulhall, J. P., et al. (2018). Evaluation and management of testosterone deficiency: AUA guideline. Journal of Urology.
• Murtola, T., et al. (2017). Percent-free PSA and prostate cancer: Clinical utility in contemporary screening. European Urology Focus.
• Pascual-Leone, A., et al. (2020). Sex hormone–binding globulin as a biomarker of cardiometabolic risk. Diabetes Care.
• Teede, H. J., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of PCOS. Human Reproduction.
• Thompson, I. M., et al. (2003). The effect of finasteride on PSA levels. Urology.
• Travison, T. G., et al. (2017). Sex hormone-binding globulin and risk of metabolic syndrome. Journal of Clinical Endocrinology & Metabolism.
• Vasan, S. K., et al. (2016). Associations of DHEA-S with cardiometabolic risk and mortality: Systematic review and meta-analysis. Journal of Clinical Endocrinology & Metabolism.
• Weiss, E. P., et al. (2009). DHEA replacement increases IGF-1 and improves quality of life in older adults: randomized controlled trial. Journal of the American Geriatrics Society.
• Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. NEJM.

In-text citation examples (APA-7):

• SHBG and metabolic syndrome relationships (Travison et al., 2017; Maggio et al., 2013)
• PCOS insulin resistance mechanisms (Lundsberg et al., 2021; Teede et al., 2018)
• MRI as gold standard for prostate evaluation (Futterer et al., 2015; Kasivisvanathan et al., 2018)
• DHEA neurosteroid actions (Maninger et al., 2009; Vasan et al., 2016)

SEO tags: SHBG and testosterone, PCOS gut dysbiosis, percent-free PSA MRI, DHEA neurosteroid libido, integrative chiropractic hormone therapy, metformin titration GLP-1 PCOS, progesterone miscarriage prevention, vitamin D hormone receptor sensitivity, testosterone therapy safety, functional medicine endocrine optimization